New hope for aggressive breast cancer: drug combo aims to wipe out tumors before surgery

This study tests whether adding the immunotherapy drug toripalimab to standard chemotherapy before surgery can completely eliminate tumors in people with localized triple-negative breast cancer. About 51 women with early-stage, untreated disease will receive the combination, then have surgery to check for remaining cancer. The goal is to see if this approach improves the chance of having no cancer left at the time of surgery.